These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28092041)

  • 1. In-Solution SH2 Domain Binding Assay Based on Proximity Ligation.
    Machida K
    Methods Mol Biol; 2017; 1555():331-347. PubMed ID: 28092041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH2-PLA: a sensitive in-solution approach for quantification of modular domain binding by proximity ligation and real-time PCR.
    Thompson CM; Bloom LR; Ogiue-Ikeda M; Machida K
    BMC Biotechnol; 2015 Jun; 15():60. PubMed ID: 26112401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding Assays Using Recombinant SH2 Domains: Far-Western, Pull-Down, and Fluorescence Polarization.
    Machida K; Liu B
    Methods Mol Biol; 2017; 1555():307-330. PubMed ID: 28092040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosette Assay: Highly Customizable Dot-Blot for SH2 Domain Screening.
    Ng KY; Machida K
    Methods Mol Biol; 2017; 1555():437-451. PubMed ID: 28092049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 Binding Site Protection Assay: A Method for Identification of SH2 Domain Interaction Partners by Exploiting SH2 Mediated Phosphosite Protection.
    Jadwin JA
    Methods Mol Biol; 2017; 1555():477-492. PubMed ID: 28092051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Efficient Semi-supervised Learning Approach to Predict SH2 Domain Mediated Interactions.
    Kundu K; Backofen R
    Methods Mol Biol; 2017; 1555():83-97. PubMed ID: 28092029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
    Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
    Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Tyrosine Phosphorylated Proteins by SH2 Domain Affinity Purification and Mass Spectrometry.
    Buhs S; Gerull H; Nollau P
    Methods Mol Biol; 2017; 1555():407-418. PubMed ID: 28092046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies.
    Jalili R; Horecka J; Swartz JR; Davis RW; Persson HHJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E925-E933. PubMed ID: 29339495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
    Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
    Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Quantification of SH2 Domain-Phosphopeptide Interactions with Cellulose-Peptide Conjugate Microarrays.
    Engelmann BW
    Methods Mol Biol; 2017; 1555():375-394. PubMed ID: 28092044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: History of SH2 Domains and Their Applications.
    Liu BA; Machida K
    Methods Mol Biol; 2017; 1555():3-35. PubMed ID: 28092024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.
    Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V
    Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.